https://scholars.lib.ntu.edu.tw/handle/123456789/624043
Title: | Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment | Authors: | Chen, Ching-Tso Feng, Yin-Hsun Yen, Chia-Jui Chen, San-Chi Lin, Yun-Tzu LI-CHUN LU CHIH-HUNG HSU ANN-LII CHENG YU-YUN SHAO |
Keywords: | Albumin-Bilirubin (ALBI) grade; Cancer of the Liver Italian Program (CLIP) score; Child–Pugh classification; Failure of Atezo-Bev treatment; Hepatocellular carcinoma; Liver function reserve; Prognosis; Second-line therapy; Systemic therapy; Treatment pattern | Issue Date: | Oct-2022 | Publisher: | SPRINGER | Journal Volume: | 16 | Journal Issue: | 5 | Start page/Pages: | 1199 | Source: | Hepatology international | Abstract: | The combination of atezolizumab and bevacizumab (Atezo-Bev) has become the standard first-line therapy for patients with advanced hepatocellular carcinoma (HCC), but the prognosis and treatment pattern after its treatment failure are unclear. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/624043 | ISSN: | 1936-0533 1936-0541 |
DOI: | 10.1007/s12072-022-10392-x |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.